Wu Q - Search Results

1

Novel Inhalable Ciprofloxacin Dry Powders for Bronchiectasis Therapy: Mannitol-Silk Fibroin Binary Microparticles with High-Payload and Improved Aerosolized Properties.

Liu C, Lin L, Huang Z, Wu Q, Jiang J, Lv L, Yu X, Quan G, Li G, Wu C. Liu C, et al. Among authors: wu c, wu q. AAPS PharmSciTech. 2019 Jan 23;20(2):85. doi: 10.1208/s12249-019-1291-5. AAPS PharmSciTech. 2019. PMID: 30673901

2

Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica.

Wang Z, Chen B, Quan G, Li F, Wu Q, Dian L, Dong Y, Li G, Wu C. Wang Z, et al. Among authors: wu c, wu q. Int J Nanomedicine. 2012;7:5807-18. doi: 10.2147/IJN.S37650. Epub 2012 Nov 22. Int J Nanomedicine. 2012. PMID: 23209366 Free PMC article.

3

Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.

Quan G, Pan X, Wang Z, Wu Q, Li G, Dian L, Chen B, Wu C. Quan G, et al. Among authors: wu c, wu q. J Nanobiotechnology. 2015 Feb 3;13:7. doi: 10.1186/s12951-015-0068-6. J Nanobiotechnology. 2015. PMID: 25643602 Free PMC article.

4

Loading amorphous Asarone in mesoporous silica SBA-15 through supercritical carbon dioxide technology to enhance dissolution and bioavailability.

Zhang Z, Quan G, Wu Q, Zhou C, Li F, Bai X, Li G, Pan X, Wu C. Zhang Z, et al. Among authors: wu c, wu q. Eur J Pharm Biopharm. 2015 May;92:28-31. doi: 10.1016/j.ejpb.2015.02.018. Epub 2015 Feb 23. Eur J Pharm Biopharm. 2015. PMID: 25720818

5

[Preparation and release behaviour of mesoporous silica/ethylcellulose sustained-release mini-matrix].

Wu QL, Quan GL, Hong Y, Wu LN, Zeng YM, Li G, Pan X, Wu CB. Wu QL, et al. Yao Xue Xue Bao. 2015 Apr;50(4):492-9. Yao Xue Xue Bao. 2015. PMID: 26223134 Chinese.

6

Erratum to: Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.

Quan G, Pan X, Wang Z, Wu Q, Li G, Dian L, Chen B, Wu C. Quan G, et al. Among authors: wu c, wu q. J Nanobiotechnology. 2015 Nov 30;13:89. doi: 10.1186/s12951-015-0104-6. J Nanobiotechnology. 2015. PMID: 26620828 Free PMC article. No abstract available.

7

Enhancing in vitro dissolution and in vivo bioavailability of fenofibrate by solid self-emulsifying matrix combined with SBA-15 mesoporous silica.

Quan G, Wu Q, Zhang X, Zhan Z, Zhou C, Chen B, Zhang Z, Li G, Pan X, Wu C. Quan G, et al. Among authors: wu c, wu q. Colloids Surf B Biointerfaces. 2016 May 1;141:476-482. doi: 10.1016/j.colsurfb.2016.02.013. Epub 2016 Feb 8. Colloids Surf B Biointerfaces. 2016. PMID: 26896653

8

Novel strategy for immunomodulation: Dissolving microneedle array encapsulating thymopentin fabricated by modified two-step molding technology.

Lin S, Cai B, Quan G, Peng T, Yao G, Zhu C, Wu Q, Ran H, Pan X, Wu C. Lin S, et al. Among authors: wu c, wu q. Eur J Pharm Biopharm. 2018 Jan;122:104-112. doi: 10.1016/j.ejpb.2017.10.011. Epub 2017 Oct 16. Eur J Pharm Biopharm. 2018. PMID: 29042238

9

Mesoporous silica nanoparticles for drug and gene delivery.

Zhou Y, Quan G, Wu Q, Zhang X, Niu B, Wu B, Huang Y, Pan X, Wu C. Zhou Y, et al. Among authors: wu c, wu b, wu q. Acta Pharm Sin B. 2018 Mar;8(2):165-177. doi: 10.1016/j.apsb.2018.01.007. Epub 2018 Feb 12. Acta Pharm Sin B. 2018. PMID: 29719777 Free PMC article. Review.

10

Fenofibrate Solid Dispersion Processed by Hot-Melt Extrusion: Elevated Bioavailability and Its Cell Transport Mechanism.

Wen T, Niu B, Wu Q, Zhou Y, Pan X, Quan G, Wu C. Wen T, et al. Among authors: wu c, wu q. Curr Drug Deliv. 2019;16(6):538-547. doi: 10.2174/1567201816666190122123044. Curr Drug Deliv. 2019. PMID: 30674259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,549 results

Search Page

Filters